Czy homocysteina moze mieć udział w patogenezie restenozy po zabiegach angioplastyki wieńcowej?

Translated title of the contribution: Is homocysteine a new factor in the pathogenesis of restenosis after percutaneous coronary angioplasty?

Piotr Jankowski, Leszek Bryniarski, Katarzyna Styczkiewicz, Grzegorz Bilo, Adam Curyło, Kalina Kawecka-Jaszcz

Research output: Contribution to journalArticle

Abstract

Restenosis after coronary angioplasty is still a significant problem despite the dynamic development of intervention cardiology. Homocysteine causes endothelial dysfunction and disorders of the coagulation system, increases in platelets aggregation and stimulates the proliferation of the vascular smooth cell. These were the reasons for investigating the relation between homocysteine level and the risk of restenosis. Some studies indicate that higher homocysteine levels increase the risk of restenosis after coronary angioplasty, while it has not been proven in other studies. The results of the only one randomized trial demonstrated that pharmacological lowering of the homocysteine level decreased the risk of restenosis after coronary angioplasty. At this time there are some studies which started focusing on the role of lowering homocysteine level in cardiovascular risk. These investigations may explain the importance of homocysteine level in the development of cardiovascular diseases. There is a need of a large prospective multicenter trial assessing the relationship between increased homocysteine level and the frequency of restenosis after coronary angioplasty. Using intravascular ultrasonography could be especially helpful in assessing the role of decreasing homocysteine level on neo-intima formation and arterial remodeling after intervention.

Original languagePolish
Pages (from-to)527-531
Number of pages5
JournalPrzeglad Lekarski
Volume60
Issue number8
Publication statusPublished - 2003

Fingerprint

Homocysteine
Angioplasty
Coronary Restenosis
Interventional Ultrasonography
Tunica Intima
Cardiology
Platelet Aggregation
Multicenter Studies
Blood Vessels
Cardiovascular Diseases
Pharmacology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jankowski, P., Bryniarski, L., Styczkiewicz, K., Bilo, G., Curyło, A., & Kawecka-Jaszcz, K. (2003). Czy homocysteina moze mieć udział w patogenezie restenozy po zabiegach angioplastyki wieńcowej? Przeglad Lekarski, 60(8), 527-531.

Czy homocysteina moze mieć udział w patogenezie restenozy po zabiegach angioplastyki wieńcowej? / Jankowski, Piotr; Bryniarski, Leszek; Styczkiewicz, Katarzyna; Bilo, Grzegorz; Curyło, Adam; Kawecka-Jaszcz, Kalina.

In: Przeglad Lekarski, Vol. 60, No. 8, 2003, p. 527-531.

Research output: Contribution to journalArticle

Jankowski, P, Bryniarski, L, Styczkiewicz, K, Bilo, G, Curyło, A & Kawecka-Jaszcz, K 2003, 'Czy homocysteina moze mieć udział w patogenezie restenozy po zabiegach angioplastyki wieńcowej?', Przeglad Lekarski, vol. 60, no. 8, pp. 527-531.
Jankowski P, Bryniarski L, Styczkiewicz K, Bilo G, Curyło A, Kawecka-Jaszcz K. Czy homocysteina moze mieć udział w patogenezie restenozy po zabiegach angioplastyki wieńcowej? Przeglad Lekarski. 2003;60(8):527-531.
Jankowski, Piotr ; Bryniarski, Leszek ; Styczkiewicz, Katarzyna ; Bilo, Grzegorz ; Curyło, Adam ; Kawecka-Jaszcz, Kalina. / Czy homocysteina moze mieć udział w patogenezie restenozy po zabiegach angioplastyki wieńcowej?. In: Przeglad Lekarski. 2003 ; Vol. 60, No. 8. pp. 527-531.
@article{7175c03244054101bc314a7f56ac4135,
title = "Czy homocysteina moze mieć udział w patogenezie restenozy po zabiegach angioplastyki wieńcowej?",
abstract = "Restenosis after coronary angioplasty is still a significant problem despite the dynamic development of intervention cardiology. Homocysteine causes endothelial dysfunction and disorders of the coagulation system, increases in platelets aggregation and stimulates the proliferation of the vascular smooth cell. These were the reasons for investigating the relation between homocysteine level and the risk of restenosis. Some studies indicate that higher homocysteine levels increase the risk of restenosis after coronary angioplasty, while it has not been proven in other studies. The results of the only one randomized trial demonstrated that pharmacological lowering of the homocysteine level decreased the risk of restenosis after coronary angioplasty. At this time there are some studies which started focusing on the role of lowering homocysteine level in cardiovascular risk. These investigations may explain the importance of homocysteine level in the development of cardiovascular diseases. There is a need of a large prospective multicenter trial assessing the relationship between increased homocysteine level and the frequency of restenosis after coronary angioplasty. Using intravascular ultrasonography could be especially helpful in assessing the role of decreasing homocysteine level on neo-intima formation and arterial remodeling after intervention.",
author = "Piotr Jankowski and Leszek Bryniarski and Katarzyna Styczkiewicz and Grzegorz Bilo and Adam Curyło and Kalina Kawecka-Jaszcz",
year = "2003",
language = "Polish",
volume = "60",
pages = "527--531",
journal = "Przeglad Lekarski",
issn = "0033-2240",
publisher = "Fundacja Lekarzy Polskich-Pro-Medica",
number = "8",

}

TY - JOUR

T1 - Czy homocysteina moze mieć udział w patogenezie restenozy po zabiegach angioplastyki wieńcowej?

AU - Jankowski, Piotr

AU - Bryniarski, Leszek

AU - Styczkiewicz, Katarzyna

AU - Bilo, Grzegorz

AU - Curyło, Adam

AU - Kawecka-Jaszcz, Kalina

PY - 2003

Y1 - 2003

N2 - Restenosis after coronary angioplasty is still a significant problem despite the dynamic development of intervention cardiology. Homocysteine causes endothelial dysfunction and disorders of the coagulation system, increases in platelets aggregation and stimulates the proliferation of the vascular smooth cell. These were the reasons for investigating the relation between homocysteine level and the risk of restenosis. Some studies indicate that higher homocysteine levels increase the risk of restenosis after coronary angioplasty, while it has not been proven in other studies. The results of the only one randomized trial demonstrated that pharmacological lowering of the homocysteine level decreased the risk of restenosis after coronary angioplasty. At this time there are some studies which started focusing on the role of lowering homocysteine level in cardiovascular risk. These investigations may explain the importance of homocysteine level in the development of cardiovascular diseases. There is a need of a large prospective multicenter trial assessing the relationship between increased homocysteine level and the frequency of restenosis after coronary angioplasty. Using intravascular ultrasonography could be especially helpful in assessing the role of decreasing homocysteine level on neo-intima formation and arterial remodeling after intervention.

AB - Restenosis after coronary angioplasty is still a significant problem despite the dynamic development of intervention cardiology. Homocysteine causes endothelial dysfunction and disorders of the coagulation system, increases in platelets aggregation and stimulates the proliferation of the vascular smooth cell. These were the reasons for investigating the relation between homocysteine level and the risk of restenosis. Some studies indicate that higher homocysteine levels increase the risk of restenosis after coronary angioplasty, while it has not been proven in other studies. The results of the only one randomized trial demonstrated that pharmacological lowering of the homocysteine level decreased the risk of restenosis after coronary angioplasty. At this time there are some studies which started focusing on the role of lowering homocysteine level in cardiovascular risk. These investigations may explain the importance of homocysteine level in the development of cardiovascular diseases. There is a need of a large prospective multicenter trial assessing the relationship between increased homocysteine level and the frequency of restenosis after coronary angioplasty. Using intravascular ultrasonography could be especially helpful in assessing the role of decreasing homocysteine level on neo-intima formation and arterial remodeling after intervention.

UR - http://www.scopus.com/inward/record.url?scp=2342622826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342622826&partnerID=8YFLogxK

M3 - Articolo

C2 - 14974346

AN - SCOPUS:2342622826

VL - 60

SP - 527

EP - 531

JO - Przeglad Lekarski

JF - Przeglad Lekarski

SN - 0033-2240

IS - 8

ER -